Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksCHEMIESYNT
statements
CHEMIESYNT

Chemiesynth (Vapi) Ltd.

BSE: 539230
Sector: Chemicals
85.28+0.0 (+0.00%)
24 Aug, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Chemiesynth (Vapi) Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
TTM
Jun 30
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
PRESS
12M
IR
Total Revenue
20.9416.4318.8921.4421.66
Cost of Operating Revenue
6.454.395.706.767.35
Gross Profit
14.4912.0413.1914.6714.31
Gross Margin
69.273.369.868.566.1
Total Operating Expenses
19.5516.2018.1121.5121.85
Operating Profit
1.390.240.78-0.07-0.19
Operating Margin
6.61.44.1-0.3-0.9
Financing Income/(Expense) - Net
-0.58-0.70-0.80-0.99-1.02
Profit before Taxes
0.81-0.45-0.01-1.05-1.18
Income Taxes
0.26-0.060.10-0.06-0.06
Profit after Tax
0.56-0.39-0.11-0.99-1.12
PAT Margin
2.7-2.4-0.6-4.6-5.2
EPS - Basic - ex Extraordinary Items
1.81-1.26-0.35-3.22-3.63
EPS - Diluted - ex Extraordinary Items
1.81-1.26-0.35-3.22-3.63
EBIT
1.390.240.78-0.07-0.19
EBITDA
2.561.542.181.351.20
EBITDA Margin
12.29.411.56.35.5

Balance Sheet

Abridged
Understanding Balance Sheet
Chemiesynth (Vapi) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
AR
AR
AR
PRESS
Total Current Assets
5.815.465.543.88
Long-Term Investments
0.440.600.610.58
Property Plant & Equipment - Net
24.5125.0825.8327.29
Total Non-Current Assets
25.2025.9126.6528.15
Total Assets
31.0131.3732.1932.03
Total Current Liabilities
9.5710.1511.8412.62
Long Term Debt
8.418.568.048.04
Total Non-Current Liabilities
9.719.889.389.36
Total Liabilities
19.2820.0321.2121.98
Total Shareholders' Equity
11.7311.3410.9810.05
Total Equity
11.7311.3410.9810.05
Total Liabilities & Equity
31.0131.3732.1932.03

Cash Flow

Abridged
Understanding Cash Flow Statement
Chemiesynth (Vapi) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
1.430.701.370.44
Working Capital - Increase/(Decrease)
-1.16-0.721.291.47
Net CF from Operating Activities
0.27-0.022.661.91
Capital Expenditures - Net
3.291.872.152.92
Net CF from Investing Activities
-3.29-1.87-2.15-2.92
Debt - LT & ST - Issuance/(Retirement) - Total
2.041.90-0.521.01
Net Cash Flow from Financing Activities
2.041.90-0.521.01
Free Cash Flow to Equity
-0.980.01-0.01-0.01
Free Operating CF net dividend
-3.04-1.890.50-1.15
Free Operating CF
-3.04-1.890.50-1.15

Business Segment Analysis

Chemiesynth (Vapi) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Chemiesynth (Vapi) Ltd.

Regional Segment Analysis

Chemiesynth (Vapi) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Chemiesynth (Vapi) Ltd.

Historical Segment Analysis

Track how Chemiesynth (Vapi) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Chemiesynth (Vapi) Ltd.

Frequently Asked Questions

What is the revenue of Chemiesynth (Vapi) Ltd.?
The latest trailing twelve month revenue of Chemiesynth (Vapi) Ltd. is ₹ 21.66 Cr, reflecting a 1-year growth of 8.24% and a 3-year CAGR of 1.38%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Chemiesynth (Vapi) Ltd.?
The latest trailing twelve month net profit (PAT) of Chemiesynth (Vapi) Ltd. is ₹ -1.12 Cr, with a 3-year earnings CAGR of -54.76%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Chemiesynth (Vapi) Ltd.?
The trailing twelve month EBITDA of Chemiesynth (Vapi) Ltd. is approximately ₹ -0.19 Cr (based on an operating margin of -0.87%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Chemiesynth (Vapi) Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Chemiesynth (Vapi) Ltd. is -3.63. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Chemiesynth (Vapi) Ltd.?
The debt-to-equity ratio of Chemiesynth (Vapi) Ltd. stands at 1.59. The interest coverage ratio is -0.18x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Chemiesynth (Vapi) Ltd.?
The estimated book value per share of Chemiesynth (Vapi) Ltd. is 32.75 (derived from a P/B ratio of 2.60 and market price of ₹ 85.28), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Chemiesynth (Vapi) Ltd.?
The trailing twelve month operating cash flow of Chemiesynth (Vapi) Ltd. is ₹ 1.91 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Chemiesynth (Vapi) Ltd. report consolidated or standalone financials?
Chemiesynth (Vapi) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.